Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary. Issue 5 (8th August 2021) - Farrell, Sheila; Karp, Jacqueline; Hager, Rebecca; Wang, Yan; Adeniyi, Oluseyi; Wang, Jie; Li, Liang; Ma, Lian; Peretz, Jackye; Summan, Mukesh; Kong, Nicolas; White, Michael; et al.